Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Feb 1;153(2):293–309. doi: 10.1084/jem.153.2.293

Histamine production during the anti-allograft response. Demonstration of a new lymphokine enhancing histamine synthesis

M Dy, B Lebel, P Kamoun, J Hamburger
PMCID: PMC2186089  PMID: 6453919

Abstract

Histamine production is greatly increased during culture of allograft recipient spleen cells in the presence of immunizing cells (secondary mixed leukocyte cultures [MLC]) as compared to that found in primary MLC (i.e., without previous allograft). This phenomenon appears after 24 h of culture and reaches its maximum at 48 h. Optimal increased histamine production is observed when MLC is performed with spleen cells removed from mice during rejection. This increased production of histamine during secondary MLC results from the action of a lymphokine: the histamine-producing cell stimulating factor (HCSF). This factor is released by T lymphocytes. Its production requires specific stimulation of the recipient lymphocytes because increase in histamine production during secondary MLC can be only observed when recipient cells are cultured with stimulating cells bearing at least one homology at K or D loci with immunizing cells. HCSF acts on a cell which is present in bone marrow, spleen, blood, and peritoneal cells but absent in thymus or lymph node cells. This target cell is found in the less-dense layer of a discontinuous Ficoll-gradient of bone marrow cells. HCSF is heat stable, destroyed by trypsin treatment, and has a molecular weight between 50,000 and 100,000. It acts on its target cells by increasing histidine decarboxylase activity.

Full Text

The Full Text of this article is available as a PDF (973.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach F. H., Grillot-Courvalin C., Kuperman O. J., Sollinger H. W., Hayes C., Sondel P. M., Alter B. J., Bach M. L. Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol Rev. 1977;35:76–96. doi: 10.1111/j.1600-065x.1977.tb00236.x. [DOI] [PubMed] [Google Scholar]
  2. Clark R. A., Sandler J. A., Gallin J. I., Kaplan A. P. Histamine modulation of eosinophil migration. J Immunol. 1977 Jan;118(1):137–145. [PubMed] [Google Scholar]
  3. Cline M. J., Golde D. W. Production of colony-stimulating activity by human lymphocytes. Nature. 1974 Apr 19;248(5450):703–704. doi: 10.1038/248703a0. [DOI] [PubMed] [Google Scholar]
  4. Denburg J. A., Davison M., Bienenstock J. Basophil production. J Clin Invest. 1980 Feb;65(2):390–399. doi: 10.1172/JCI109682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dimitriu A., Dy M., Thomson N., Hamburger J. Macrophage cytotoxicity in the mouse immune response against a skin allograft. J Immunol. 1975 Jan;114(1 Pt 1):195–199. [PubMed] [Google Scholar]
  6. Dvorak H. F. Role of the basophilic leukocyte in allograft rejection. J Immunol. 1971 Jan;106(1):279–281. [PubMed] [Google Scholar]
  7. Dy M., Astoin M., Rigaud M., Hamburger J. Prostaglandin (PG) release in the mixed lymphocyte culture; effect of presensitization by a skin allograft; nature of the PG-producing cell. Eur J Immunol. 1980 Feb;10(2):121–126. doi: 10.1002/eji.1830100210. [DOI] [PubMed] [Google Scholar]
  8. Dy M., Kamoun P., Hamburger J. Production d'urée au cours des cultures mixtes leucocytaires (MLC). Effet d'une présensibilisation par une allogreffe de peau. C R Seances Acad Sci D. 1979 Dec 17;289(16):1245–1249. [PubMed] [Google Scholar]
  9. Guy-Grand D., Griscelli C., Vassalli P. The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions. J Exp Med. 1978 Dec 1;148(6):1661–1677. doi: 10.1084/jem.148.6.1661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ishizaka T., Ishizaka K. Biology of immunoglobulin E. Molecular basis of reaginic hypersensitivity. Prog Allergy. 1975;19:60–121. [PubMed] [Google Scholar]
  11. Kelly M. T., Martin R. R., White A. Mediators of histamine release from human platelets, lymphocytes, and granulocytes. J Clin Invest. 1971 May;50(5):1044–1049. doi: 10.1172/JCI106575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kitamura Y., Hatanaka K., Murakami M., Shibata H. Presence of mast cell precursors in peripheral blood of mice demonstrated by parabiosis. Blood. 1979 Jun;53(6):1085–1088. [PubMed] [Google Scholar]
  13. Kitamura Y., Shimada M., Go S., Matsuda H., Hatanaka K., Seki M. Distribution of mast-cell precursors in hematopoeitic and lymphopoietic tissues of mice. J Exp Med. 1979 Sep 19;150(3):482–490. doi: 10.1084/jem.150.3.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lett-Brown M. A., Leonard E. J. Histamine-induced inhibition of normal human basophil chemotaxis to C5a. J Immunol. 1977 Mar;118(3):815–818. [PubMed] [Google Scholar]
  15. Lichtenstein L. M., Gillespie E. Inhibition of histamine release by histamine controlled by H2 receptor. Nature. 1973 Aug 3;244(5414):287–288. doi: 10.1038/244287a0. [DOI] [PubMed] [Google Scholar]
  16. Miller H. R., Walshaw R. Immune reactions in mucous membranes. IV. Histochemistry of intestinal mast cells during helminth expulsion in the rat. Am J Pathol. 1972 Oct;69(1):195–208. [PMC free article] [PubMed] [Google Scholar]
  17. Moore T. C., Chang J. K. Urinary histamine excretion in the rat following skin homografting and autografting. Ann Surg. 1968 Feb;167(2):232–238. doi: 10.1097/00000658-196802000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Moore T. C. Histidine decarboxylase inhibitors and the survival of skin homofrafts. Nature. 1967 Aug 19;215(5103):871–872. doi: 10.1038/215871a0. [DOI] [PubMed] [Google Scholar]
  19. Papiernik M., Bach J. F. Thymocyte subpopulations in young and adult mice. II. Study of steroid-resistant populations by means of a specific heteroantiserum. Eur J Immunol. 1977 Nov;7(11):800–803. doi: 10.1002/eji.1830071111. [DOI] [PubMed] [Google Scholar]
  20. Pla M., Colombani J. M. Etude des déterminants responsables de la stimulation lors de la réaction lymphocytaire mixte secondaire (MLR-II). C R Seances Acad Sci D. 1979 Sep 24;289(5):477–480. [PubMed] [Google Scholar]
  21. Ritchie D. G., Levy D. A. A microassay for mammalian histidine decarboxylase. Anal Biochem. 1975 May 26;66(1):194–205. doi: 10.1016/0003-2697(75)90737-x. [DOI] [PubMed] [Google Scholar]
  22. Rocklin R. E., Greineder D. K., Melmon K. L. Histamine-induced suppressor factor (HSF): further studies on the nature of the stimulus and the cell which produces it. Cell Immunol. 1979 May;44(2):404–415. doi: 10.1016/0008-8749(79)90015-7. [DOI] [PubMed] [Google Scholar]
  23. Rocklin R. E., Greineder D., Littman B. H., Melmon K. L. Modulation of cellular immune function in vitro by histamine receptor-bearing lymphocytes: mechanism of action. Cell Immunol. 1978 Apr;37(1):162–173. doi: 10.1016/0008-8749(78)90184-3. [DOI] [PubMed] [Google Scholar]
  24. Rocklin R. E. Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. J Clin Invest. 1976 Apr;57(4):1051–1058. doi: 10.1172/JCI108347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ruscetti F. W., Chervenick P. A. Release of colony-stimulating activity from thymus-derived lymphocytes. J Clin Invest. 1975 Mar;55(3):520–527. doi: 10.1172/JCI107958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ruscetti F. W., Cypess R. H., Chervenick P. A. Specific release of neutrophillic- and eosinophilic-stimulating factors from sensitized lymphocytes. Blood. 1976 May;47(5):757–765. [PubMed] [Google Scholar]
  27. SHORE P. A., BURKHALTER A., COHN V. H., Jr A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 1959 Nov;127:182–186. [PubMed] [Google Scholar]
  28. Shearer G. M., Melmon K. L., Weinstein Y., Sela M. Regulation of antibody response by cells expressing histamine receptors. J Exp Med. 1972 Nov 1;136(5):1302–1307. doi: 10.1084/jem.136.5.1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Siraganian R. P. Automated histamine analysis for in vitro allergy testing. II. Correlation of skin test results with in vitro whole blood histamine release in 82 patients. J Allergy Clin Immunol. 1977 Mar;59(3):214–222. doi: 10.1016/0091-6749(77)90152-x. [DOI] [PubMed] [Google Scholar]
  30. Thomson N., Dimitriu A., Dy M., Hamburger J. Kinetics of development of the inhibitory activity of mixed lymphocyte culture supernatants on macrophage migration: effect of presensitization. Cell Immunol. 1974 May;12(2):247–251. doi: 10.1016/0008-8749(74)90076-8. [DOI] [PubMed] [Google Scholar]
  31. Thueson D. O., Speck L. S., Lett-Brown M. A., Grant J. A. Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol. 1979 Aug;123(2):626–632. [PubMed] [Google Scholar]
  32. Thueson D. O., Speck L. S., Lett-Brown M. A., Grant J. A. Histamine-releasing activity (HRA). II. Interaction with basophils and physicochemical characterization. J Immunol. 1979 Aug;123(2):633–639. [PubMed] [Google Scholar]
  33. Wang S. R., Zweiman B. Histamine suppression of human lymphocyte responses to mitogens. Cell Immunol. 1978 Mar 1;36(1):28–36. doi: 10.1016/0008-8749(78)90247-2. [DOI] [PubMed] [Google Scholar]
  34. Yu D. T., Peter B. J., Paulus H. E., Machleder H. I. Lymphocyte populations: separation by discontinuous density gradient centrifugation. J Immunol. 1973 Jun;110(6):1615–1622. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES